Marshall Wace, LLP Ginkgo Bioworks Holdings, Inc. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.06 - $1.67 $577,129 - $909,251
544,462 New
544,462 $631,000
Q2 2022

Aug 15, 2022
SELL
$2.2 - $4.2 $1.93 Million - $3.68 Million
-875,207 Reduced 69.31%
387,518 $924,000
Q1 2022

May 16, 2022
BUY
$2.83 - $8.69 $3.27 Million - $10 Million
1,154,467 Added 1066.4%
1,262,725 $5.09 Million
Q4 2021

Feb 14, 2022
BUY
$8.31 - $14.92 $899,623 - $1.62 Million
108,258 New
108,258 $899,000

Others Institutions Holding DNA

# of Institutions
40
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email